Antiretroviral therapy coverage for PMTCT in Algeria
Algeria: Antiretroviral therapy coverage for PMTCT was 74.0% in 2019. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Algeria, 2000–2019
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2019, antiretroviral therapy coverage for pmtct in Algeria stood at 74.0%. That is the highest value across all 20 years on record.
Compared with earlier readings it is up 5.7% on the previous year and up 131.2% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Algeria peaked at 74.0% in 2019 and was at its lowest, 0.0%, in 2000.
That places Algeria 48th out of 84 countries with data for 2019, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Algeria, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 37.0% | — |
| 2009 | 32.0% | -13.5% |
| 2010 | 53.0% | +65.6% |
| 2011 | 51.0% | -3.8% |
| 2012 | 42.0% | -17.6% |
| 2013 | 64.0% | +52.4% |
| 2014 | 32.0% | -50.0% |
| 2015 | 29.0% | -9.4% |
| 2016 | 50.0% | +72.4% |
| 2017 | 60.0% | +20.0% |
| 2018 | 70.0% | +16.7% |
| 2019 | 74.0% | +5.7% |
Algeria compared with similar countries
- Algeria's 74.0% is below the median for upper middle income countries, which is 79.5%, 93% of the median. (22 countries reporting)
- Algeria's 74.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 2.3× the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.9% | 0.0% | 37.0% | 10 |
| 2010s | 52.5% | 29.0% | 74.0% | 10 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Algeria?
- Antiretroviral therapy coverage for pmtct in Algeria was 74.0% in 2019, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Algeria?
- The highest recorded value was 74.0% in 2019.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Algeria?
- The lowest recorded value was 0.0% in 2000.
- How does Algeria rank for antiretroviral therapy coverage for pmtct?
- Algeria ranks 48th out of 84 countries with data for 2019.
- Is antiretroviral therapy coverage for pmtct rising or falling in Algeria?
- Over the last ten years it is up 131.2%. The long-run trend across the full record is volatile.
- Where does this Algeria data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).